FourThought Financial, LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 190 filers reported holding HERON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
FourThought Financial, LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$17,000
+54.5%
4,0230.0%0.00%
+50.0%
Q2 2022$11,000
-52.2%
4,0230.0%0.00%
-33.3%
Q1 2022$23,000
-28.1%
4,023
+15.3%
0.00%
-25.0%
Q4 2021$32,000
-13.5%
3,4880.0%0.00%
-20.0%
Q3 2021$37,000
-30.2%
3,488
+2.1%
0.01%
-28.6%
Q2 2021$53,000
-10.2%
3,417
-6.1%
0.01%
-22.2%
Q1 2021$59,000
-28.0%
3,640
-6.5%
0.01%
-30.8%
Q4 2020$82,0003,8950.01%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders